Category : Search result: Trump drug prices NHS pharmaceuticals healthcare USUK relations medication costs


Glasgow: Europe's Drug Death Capital Exposed

Shocking investigation reveals Glasgow's grim status as Europe's drug death capital, with open-air drug use and discarded needles plaguing the city centre. Exclusive footage and expert insights expose a deepening public health emergency.

AI Doctors: The NHS's Prescription for the Future?

Exclusive insight into how AI physicians could solve the NHS crisis, reduce waiting times, and provide 24/7 medical expertise. Discover why leading experts believe artificial intelligence may become your first point of medical contact.

40% Surge in ADHD Drugs for UK Preschoolers

Exclusive NHS data reveals a sharp 40% rise in ADHD drug prescriptions for preschool children under five, raising serious ethical and safety concerns among medical experts.

Trump Tariffs Threaten UK Ozempic and Mounjaro Supplies

Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.

NHS Crisis Forces Record Numbers to Go Private

Exclusive analysis reveals a dramatic surge in Britons turning to private medical care, driven by unprecedented NHS waiting times and a perceived 'postcode lottery' for treatment. This investigation uncovers the human cost of the healthcare crisis.

Trump Tariffs Threaten UK Access to Weight-Loss Drugs

A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.

Ozempic & Mounjaro Prices Rise Due to Trump Tariffs

Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.

Eli Lilly hikes Mounjaro price in UK for 2025

Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.

Starmer's bold plan to cut UK drug prices

Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?

NHS faces critical staff shortages in new report

A recent report highlights severe staffing shortages within the NHS, raising concerns over patient care and service sustainability. Experts warn of growing pressures on healthcare workers.

Page 4 of 4